Literature DB >> 34622398

Identification and Characterization of the miRNAs and Cytokines in Response to Leishmania infantum Infection with Different Response to Treatment.

Helena Hanif1, Saeed Akbari2, Vahid Rahnama3, Hossein Vazini4, Fatemeh Javani Jouni5.   

Abstract

PURPOSE: Due to the complexity of cytokine and microRNA function in progression and/or suppression of an infection, in this study, we examined miR-3473f, miR-2128, miR-6994-5p, miR-7093-3p, miR-5128, miR-574-5p, miR-7235, IL-2, IL-4, IL-5, IL-10 and IL-13 in patients with VL caused by Leishmania infantum in an in vivo study.
METHODS: Sampling was carried out from patient with leishmaniasis and with different responses to treatment during March 2016-January 2020. DNA was extracted and purified using QIAamp Kit. The L. infantum were cultured in DMEM medium and protein content was determined by the Micro BCA Protein Assay Kit. Cytokines were evaluated using a MILLIPLEX MAP Mouse Cytokine/Chemokine Panel I kit. The relative expression of miRNAs was measured in duplicate using automatic thermocycler ABI Prism 7500 sequence detection system (Applied Bio-systems) using the TaqMan MicroRNA Assay kit.
RESULTS: The real-time PCR assay revealed that miR-2128, miR-6994-5p, miR-7093-3p, miR-5128, miR-574-5p and miR-7235 were down-regulated and miR-3473 were up-regulated in patients with semi-resistance and resistance parasite strain (P < 0.05). In the current work, cytokine patterns in patients who were slow-to-clear or unable-to-clear L. infantum infection during drug treatment were seen to have decreased protective Th1 cytokines (IL-2, IL-12, TNF-α, and IFN-ɤ, P < 0.001) and increased Th2 cytokines (IL-5, IL-10, and IL-13, P < 0.001). No association was seen with IL-4 in patients with different treatment outcomes.
CONCLUSION: Overall, the results of a recent study have shown that cytokines and microRNAs can play a key role in response to treatment, and more comprehensive studies are needed to support this hypothesis.
© 2021. Witold Stefański Institute of Parasitology, Polish Academy of Sciences.

Entities:  

Keywords:  Cytokine; L. infantum; Leishmaniasis; miRNAs

Mesh:

Substances:

Year:  2021        PMID: 34622398     DOI: 10.1007/s11686-021-00474-5

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  25 in total

Review 1.  Advances in leishmaniasis.

Authors:  Henry W Murray; Jonathan D Berman; Clive R Davies; Nancy G Saravia
Journal:  Lancet       Date:  2005 Oct 29-Nov 4       Impact factor: 79.321

2.  Real-time quantitative reverse transcription-PCR analysis of expression stability of Aggregatibacter actinomycetemcomitans fimbria-associated gene in response to photodynamic therapy.

Authors:  Maryam Pourhajibagher; Abbas Monzavi; Nasim Chiniforush; Mohammad Moein Monzavi; Shaghayegh Sobhani; Sima Shahabi; Abbas Bahador
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-02-16       Impact factor: 3.631

Review 3.  Visceral leishmaniasis.

Authors:  Johan van Griensven; Ermias Diro
Journal:  Infect Dis Clin North Am       Date:  2012-04-24       Impact factor: 5.982

4.  Monitoring gene expression of rcpA from Aggregatibacter actinomycetemcomitans versus antimicrobial photodynamic therapy by relative quantitative real-time PCR.

Authors:  Maryam Pourhajibagher; Nasim Chiniforush; Sima Shahabi; Shaghayegh Sobhani; Mohammad Moein Monzavi; Abbas Monzavi; Abbas Bahador
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-04-24       Impact factor: 3.631

Review 5.  Current and emerging medications for the treatment of leishmaniasis.

Authors:  Jaya Chakravarty; Shyam Sundar
Journal:  Expert Opin Pharmacother       Date:  2019-05-07       Impact factor: 3.889

6.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 7.  Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features.

Authors:  Mehdi Mohebali
Journal:  Iran J Parasitol       Date:  2013-07       Impact factor: 1.012

8.  Genotyping Leishmania promastigotes isolated from patients with cutaneous leishmaniasis in south-eastern Turkey.

Authors:  Fahriye Ekşi; Orhan Özgöztaşı; Tekin Karslıgil; Mustafa Sağlam
Journal:  J Int Med Res       Date:  2017-01-12       Impact factor: 1.671

9.  The Comparison of the IFN-ɤ, TNF-α and IL-10 Cytokines in Healing and Non-healing Cutaneous Leishmaniasis.

Authors:  Mina Taraghian; Helena Hanif; Parisa Mousavi; Zahra Baharlooeyan Cheshmeh; Azam Samei; Abbas Abdollahi; Hossein Vazini
Journal:  Iran J Parasitol       Date:  2021 Jul-Sep       Impact factor: 1.012

10.  Potent antileishmanial activity of chitosan against Iranian strain of Leishmania major (MRHO/IR/75/ER): In vitro and in vivo assay.

Authors:  Bahman Rahimi Esboei; Mehdi Mohebali; Parisa Mousavi; Mahdi Fakhar; Behnaz Akhoundi
Journal:  J Vector Borne Dis       Date:  2018 Apr-Jun       Impact factor: 1.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.